litlas
ログインアカウント作成

Hubert Schrezenmeier

1986–2025 年に発表

157
論文数
21,546
被引用数
85
h 指数
154
i10 指数

被引用数

Hubert Schrezenmeier の年別被引用数1983 年: 被引用 3 件1987 年: 被引用 4 件1988 年: 被引用 3 件1989 年: 被引用 18 件1990 年: 被引用 20 件1991 年: 被引用 19 件1992 年: 被引用 13 件1993 年: 被引用 14 件1994 年: 被引用 14 件1995 年: 被引用 18 件1996 年: 被引用 9 件1997 年: 被引用 20 件1998 年: 被引用 15 件1999 年: 被引用 23 件2000 年: 被引用 40 件2001 年: 被引用 15 件2002 年: 被引用 25 件2003 年: 被引用 41 件2004 年: 被引用 12 件2005 年: 被引用 22 件2006 年: 被引用 31 件2007 年: 被引用 79 件2008 年: 被引用 67 件2009 年: 被引用 111 件2010 年: 被引用 88 件2011 年: 被引用 116 件2012 年: 被引用 130 件2013 年: 被引用 150 件2014 年: 被引用 173 件2015 年: 被引用 192 件2016 年: 被引用 154 件2017 年: 被引用 145 件2018 年: 被引用 154 件2019 年: 被引用 534 件2020 年: 被引用 686 件2021 年: 被引用 1,034 件2022 年: 被引用 953 件2023 年: 被引用 461 件2024 年: 被引用 691 件2025 年: 被引用 262 件2026 年: 被引用 5 件1984〜1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,807 件、この内訳の 22%ドイツ: 引用元論文 783 件、この内訳の 9.5%中国: 引用元論文 621 件、この内訳の 7.5%イギリス: 引用元論文 589 件、この内訳の 7.2%フランス: 引用元論文 464 件、この内訳の 5.6%イタリア: 引用元論文 460 件、この内訳の 5.6%オランダ: 引用元論文 269 件、この内訳の 3.3%スイス: 引用元論文 255 件、この内訳の 3.1%日本: 引用元論文 252 件、この内訳の 3.1%スペイン: 引用元論文 226 件、この内訳の 2.7%カナダ: 引用元論文 218 件、この内訳の 2.7%オーストラリア: 引用元論文 157 件、この内訳の 1.9%
0%22%その他 25.8%

機関

分野

  • Medicine62.6%
  • Immunology and Microbiology19%
  • Biochemistry, Genetics and Molecular Biology10.8%
  • Materials Science2.3%
  • Engineering1.7%
  • Neuroscience1.4%
  • その他2.2%

トピック

  • SARS-CoV-2 and COVID-19 Research6.3%
  • Hematopoietic Stem Cell Transplantation4.8%
  • Complement system in diseases4.6%
  • Mesenchymal stem cell research4.4%
  • COVID-19 Clinical Research Studies3.8%
  • Acute Myeloid Leukemia Research2.5%
  • その他73.6%

共著者

全論文

検索で開く
  1. The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

    著者: Peter Hillmen, Neal S. Young, Jörg Schubert, Robert A. Brodsky, Gèrard Socié, Petra Muus, Alexander Röth, Jeff Szer, Modupe Elebute, Ryotaro Nakamura, Paul Browne, Antonio M. Risitano, Anita Hill, Hubert Schrezenmeier, Chieh‐Lin Fu, Jaroslaw P. Maciejewski, Scott A. Rollins, Christopher F. Mojcik, Russell P. Rother, Lucio Luzzatto - New England Journal of Medicine 2006 被引用: 1,272

  2. Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study

    著者: Jong Wook Lee, Flore Sicre de Fontbrune, Lily Wong Lee Lee, Viviani Pessôa, Sandra Fátima Menosi Gualandro, Wolfgang Füreder, В. В. Птушкин, Scott T. Rottinghaus, Lori Volles, Lori Shafner, Rasha Aguzzi, Rajendra Pradhan, Hubert Schrezenmeier, Anita Hill - Blood 2018 被引用: 400

  3. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

    著者: Markus Hoffmann, Prerna Arora, Rüdiger Groß, Alina Seidel, Bojan F. Hörnich, Alexander S. Hahn, Nadine Krüger, Luise Graichen, Heike Hofmann-Winkler, Amy Kempf, Martin Sebastian Winkler, Sebastian Schulz, Hans‐Martin Jäck, Bernd Jahrsdörfer, Hubert Schrezenmeier, Martin Müller, Alexander Kleger, Jan Münch, Stefan Pöhlmann - Cell 2021 被引用: 1,049

  4. Cdc42 Activity Regulates Hematopoietic Stem Cell Aging and Rejuvenation

    著者: Maria Carolina Florian, Karin Dörr, Anja Niebel, Deidre Daria, Hubert Schrezenmeier, Markus Rojewski, Marie–Dominique Filippi, Anja Hasenberg, Matthias Gunzer, Karin Scharffetter‐­Kochanek, Yi Zheng, Hartmut Geiger - Cell stem cell 2012 被引用: 576

  5. Interleukin 21–Induced Granzyme B–Expressing B Cells Infiltrate Tumors and Regulate T Cells

    著者: Stefanie Lindner, Karen Dahlke, Kai Sontheimer, Magdalena Hagn, Christof Kaltenmeier, Thomas F.E. Barth, Thamara Beyer, Frank Reister, Dorit Fabricius, Ramin Lotfi, Oleg Lunov, G. Ulrich Nienhaus, Thomas Simmet, R. Kreienberg, Peter Möller, Hubert Schrezenmeier, Bernd Jahrsdörfer - Cancer Research 2013 被引用: 342

  6. Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria

    著者: Régis Peffault de Latour, Alexander Röth, Austin Kulasekararaj, Bing Han, Phillip Scheinberg, Jaroslaw P. Maciejewski, Yasutaka Ueda, Carlos M. de Castro, Eros Di Bona, Rong Fu, Zhang Li, Morag Griffin, Saskia Langemeijer, Jens Panse, Hubert Schrezenmeier, Wilma Barcellini, Vitor AQ Mauad, Philippe Schafhausen, Suzanne Tavitian, Eloise Beggiato, Lee Ping Chew, Anna Gayà, Wei‐Han Huang, Jun Ho Jang, Toshio Heike, Abdullah Kutlar, Rosario Notaro, Vinod Pullarkat, Jörg Schubert, Louis Terriou, Michihiro Uchiyama, Lily Wong Lee Lee, Eng Soo Yap, Flore Sicre de Fontbrune, Luana Marano, Ferras Alashkar, Shreyans Gandhi, Roochi Trikha, Yang Chen, Hui Liu, Richard Kelly, Britta Höchsmann, Cécile Kerloëguen, P. S. Banerjee, Rafael Levitch, Rakesh Kumar, Zhixin Wang, Christine Thorburn, Samopriyo Maitra, Shujie Li, Aurélie Verles, Marion Dahlke, Antonio M. Risitano - New England Journal of Medicine 2024 被引用: 141

  7. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

    著者: Robert A. Brodsky, Neal S. Young, Elisabetta Antonioli, Antonio M. Risitano, Hubert Schrezenmeier, Jörg Schubert, Anna Gayà, Luke Coyle, Carlos de Castro Lozano, Chieh‐Lin Fu, Jaroslaw P. Maciejewski, Monica Bessler, Henk-André Kroon, Russell P. Rother, Peter Hillmen - Blood 2007 被引用: 653

  8. Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation

    著者: Mareike Frick, Willy Chan, Christopher Maximilian Arends, Raphael Hablesreiter, Adriane Halik, Michael Heuser, David Michonneau, Olga Blau, Kaja Hoyer, Friederike Christen, Joel Galan-Sousa, Daniel Noerenberg, Verena Wais, Michael Stadler, Kenichi Yoshida, Johannes Schetelig, Esther Schuler, Felicitas Thol, Emmanuelle Clappier, Maximilian Christopeit, Francis Ayuk, Martin Bornhäuser, Igor Wolfgang Blau, Seishi Ogawa, Tomasz Żemojtel, Armin Gerbitz, Eva Wagner, Bernd M. Spriewald, Hubert Schrezenmeier, Florian Kuchenbauer, Guido Kobbe, Markus Wiesneth, Michael Koldehoff, Gèrard Socié, Nicolaus Kröger, Lars Bullinger, Christian Thiede, Frédérik Damm - Journal of Clinical Oncology 2018 被引用: 220

  9. Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial

    著者: Cecilie Gjerde, Kamal Mustafa, Sølve Hellem, Markus Rojewski, Harald Gjengedal, Mohammed A. Yassin, Xin Feng, Siren Skaale, Trond Inge Berge, Annika Rosén, Xie‐Qi Shi, Aymen Ahmed, Bjørn Tore Gjertsen, Hubert Schrezenmeier, Pierre Layrolle - Stem Cell Research & Therapy 2018 被引用: 195

  10. The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria

    著者: Alexander Röth, J Nishimura, Zsolt Nagy, Júlia Gaál-Weisinger, Jens Panse, Sung‐Soo Yoon, Miklós Egyed, Satoshi Ichikawa, Yoshikazu Ito, Jin Seok Kim, Haruhiko Ninomiya, Hubert Schrezenmeier, Simona Sica, Kensuke Usuki, Flore Sicre de Fontbrune, Juliette Soret, Alexandre Sostelly, James Higginson, Andreas Dieckmann, Brittany Gentile, Judith Anzures‐Cabrera, Kenji Shinomiya, Gregor Jordan, Marta Biedzka-Sarek, Barbara Klughammer, Angelika Jahreis, Christoph Bucher, Régis Peffault de Latour - Blood 2020 被引用: 130

  11. Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria

    著者: Richard J. Kelly, Britta Höchsmann, Jeff Szer, Austin Kulasekararaj, Sophie de Guibert, Alexander Röth, Ilene C. Weitz, Elina Armstrong, Antonio M. Risitano, Christopher J. Patriquin, Louis Terriou, Petra Muus, Anita Hill, Michelle Turner, Hubert Schrezenmeier, Régis Peffault de Latour - New England Journal of Medicine 2015 被引用: 275

  12. Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry

    著者: Hubert Schrezenmeier, Alexander Röth, David J. Araten, Yuzuru Kanakura, Loree Larratt, Jamile M. Shammo, Amanda Wilson, Gilda Shayan, Jaroslaw P. Maciejewski - Annals of Hematology 2020 被引用: 156

  13. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria

    著者: Peter Hillmen, Petra Muus, Ulrich Dührsen, Antonio M. Risitano, Jörg Schubert, Lucio Luzzatto, Hubert Schrezenmeier, Jeff Szer, Robert A. Brodsky, Anita Hill, Gèrard Socié, Monica Bessler, Scott A. Rollins, Leonard Bell, Russell P. Rother, Neal S. Young - Blood 2007 被引用: 578

  14. Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity

    著者: Marco Mannes, Arthur Dopler, Oliver Zolk, Sophia J. Lang, Rebecca Halbgebauer, Britta Höchsmann, Arne Skerra, Christian Braun, Markus Huber‐Lang, Hubert Schrezenmeier, Christoph Q. Schmidt - Blood 2020 被引用: 100

  15. Early efficacy evaluation of mesenchymal stromal cells (MSC) combined to biomaterials to treat long bone non-unions

    著者: Enrique Gómez‐Barrena, Norma G. Padilla-Eguiluz, Philippe Rosset, Florian Gebhard, Philippe Hernigou, Nicola Baldini, Hélène Rouard, Luc Sensebé, Rosa-María Gonzalo-Daganzo, Rosaria Giordano, Eduardo García‐Rey, José Cordero‐Ampuero, Juan Carlos Rubio-Suárez, Marta Dominguez García-Simón, Julien Stanovici, Christian Ehrnthaller, Markus Huber‐Lang, Charles Henri Flouzat-Lachaniette, Nathalie Chevallier, Davide María Donati, Benedetta Spazzoli, G. Ciapetti, Sandrine Fleury‐Cappellesso, M Rodriguez Fernandez, José-Rafael Cabrera, C. Avendaño, Tiziana Montemurro, Carmen Panaitescu, Elena Veronesi, Markus Rojewski, Ramin Lotfi, Massimo Dominici, Hubert Schrezenmeier, Pierre Layrolle - Injury 2020 被引用: 76

  16. A Differentiation Checkpoint Limits Hematopoietic Stem Cell Self-Renewal in Response to DNA Damage

    著者: Jianwei Wang, Qian Sun, Yohei Morita, Hong Jiang, Alexander Groß, André Lechel, Kai Hildner, Luis Miguel Guachalla, Anne Gompf, Daniel Hartmann, Axel Schambach, Torsten Wüestefeld, Daniel Dauch, Hubert Schrezenmeier, Wolf‐Karsten Hofmann, Hiromitsu Nakauchi, Zhenyu Ju, Hans A. Kestler, Lars Zender, K. Lenhard Rudolph - Cell 2012 被引用: 339

  17. TSG-6 Released from Intradermally Injected Mesenchymal Stem Cells Accelerates Wound Healing and Reduces Tissue Fibrosis in Murine Full-Thickness Skin Wounds

    著者: Qi Yu, Dongsheng Jiang, Anca Sindrilaru, Agatha Stegemann, Susanne Schatz, Nicolai Treiber, Markus Rojewski, Hubert Schrezenmeier, Seppe Vander Beken, Meinhard Wlaschek, Markus Böhm, Andreas Martin Seitz, N. Scholz, Lutz Dürselen, Jürgen Brinckmann, Anita Ignatius, Karin Scharffetter‐­Kochanek - Journal of Investigative Dermatology 2013 被引用: 251

  18. Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria

    著者: Robert A. Brodsky, Régis Peffault de Latour, Scott T. Rottinghaus, Alexander Röth, Antonio M. Risitano, Ilene C. Weitz, Peter Hillmen, Jaroslaw P. Maciejewski, Jeff Szer, Jong Wook Lee, Austin Kulasekararaj, Lori Volles, Andrew I. Damokosh, Stephan Ortiz, Lori Shafner, Peng Liu, Anita Hill, Hubert Schrezenmeier - Haematologica 2020 被引用: 125

  19. A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactor

    著者: Viktoria Jakl, Melanie Ehmele, M. Winkelmann, Simon Ehrenberg, Tim Eiseler, Benedikt Friemert, Markus Rojewski, Hubert Schrezenmeier - Frontiers in Bioengineering and Biotechnology 2023 被引用: 39

  20. Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change

    著者: Maximilian Christopeit, Oliver Kuß, Jürgen Finke, Ulrike Bacher, Dietrich W. Beelen, Martin Bornhäuser, Rainer Schwerdtfeger, Wolfgang Bethge, Nadežda Basara, Martin Gramatzki, Johanna Tischer, Hans‐Jochem Kolb, Lutz Uharek, Ralf G. Meyer, Donald Bunjes, Christof Scheid, Hans Martin, Dietger Niederwieser, Nicolaus Kröger, Hartmut Bertz, Hubert Schrezenmeier, Christoph Schmid - Journal of Clinical Oncology 2013 被引用: 173

  21. Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation

    著者: Markus J. Harder, Nadine Kuhn, Hubert Schrezenmeier, Britta Höchsmann, Inge von Zabern, Christof Weinstock, Thomas Simmet, Daniel Ricklin, John D. Lambris, Arne Skerra, Markus Anliker, Christoph Q. Schmidt - Blood 2016 被引用: 139

  22. Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria

    著者: Peter Hillmen, Petra Muus, Alexander Röth, Modupe Elebute, Antonio M. Risitano, Hubert Schrezenmeier, Jeff Szer, Paul Browne, Jaroslaw P. Maciejewski, Jörg Schubert, Álvaro Urbano-Ispizúa, Carlos de Castro, Gèrard Socié, Robert A. Brodsky - British Journal of Haematology 2013 被引用: 387

  23. Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry

    著者: Hubert Schrezenmeier, Petra Muus, G. Socié, Jeff Szer, Álvaro Urbano-Ispizúa, Jaroslaw P. Maciejewski, Robert A. Brodsky, Monica Bessler, Yuzuru Kanakura, Wendell F. Rosse, Gus Khursigara, Camille L. Bedrosian, Peter Hillmen - Haematologica 2014 被引用: 266

  24. Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies

    著者: Alexander Röth, Scott T. Rottinghaus, Anita Hill, Eric Bachman, Jin Seok Kim, Hubert Schrezenmeier, Louis Terriou, Álvaro Urbano-Ispizúa, Richard A. Wells, Jun Ho Jang, Austin Kulasekararaj, Jeff Szer, Rasha Aguzzi, Andrew I. Damokosh, Lori Shafner, Jong Wook Lee - Blood Advances 2018 被引用: 85